Loading…

The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study

To investigate the association of air pollution exposure with the severity of interstitial lung disease (ILD) at diagnosis and ILD progression among patients with systemic sclerosis (SSc)-associated ILD. We conducted a retrospective two-center study of patients with SSc-associated ILD diagnosed betw...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory research 2023-06, Vol.24 (1), p.151-151, Article 151
Main Authors: Roeser, Anaïs, Sese, Lucile, Chassagnon, Guillaume, Chaigne, Benjamin, Dunogue, Bertrand, Tran Ba, Stéphane, Jebri, Salma, Brillet, Pierre-Yves, Revel, Marie Pierre, Aubourg, Frédérique, Dhote, Robin, Caux, Frédéric, Annesi-Maesano, Isabella, Mouthon, Luc, Nunes, Hilario, Uzunhan, Yurdagül
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c564t-607b4e4b2d70292cd9f07eb3625bcc4e04fdb289a9c45a0d9d2febaa4c7c5f2b3
cites cdi_FETCH-LOGICAL-c564t-607b4e4b2d70292cd9f07eb3625bcc4e04fdb289a9c45a0d9d2febaa4c7c5f2b3
container_end_page 151
container_issue 1
container_start_page 151
container_title Respiratory research
container_volume 24
creator Roeser, Anaïs
Sese, Lucile
Chassagnon, Guillaume
Chaigne, Benjamin
Dunogue, Bertrand
Tran Ba, Stéphane
Jebri, Salma
Brillet, Pierre-Yves
Revel, Marie Pierre
Aubourg, Frédérique
Dhote, Robin
Caux, Frédéric
Annesi-Maesano, Isabella
Mouthon, Luc
Nunes, Hilario
Uzunhan, Yurdagül
description To investigate the association of air pollution exposure with the severity of interstitial lung disease (ILD) at diagnosis and ILD progression among patients with systemic sclerosis (SSc)-associated ILD. We conducted a retrospective two-center study of patients with SSc-associated ILD diagnosed between 2006 and 2019. Exposure to the air pollutants particulate matter of up to 10 and 2.5 µm in diameter (PM , PM ), nitrogen dioxide (NO ), and ozone (O ) was assessed at the geolocalization coordinates of the patients' residential address. Logistic regression models were used to evaluate the association between air pollution and severity at diagnosis according to the Goh staging algorithm, and progression at 12 and 24 months. We included 181 patients, 80% of whom were women; 44% had diffuse cutaneous scleroderma, and 56% had anti-topoisomerase I antibodies. ILD was extensive, according to the Goh staging algorithm, in 29% of patients. O exposure was associated with the presence of extensive ILD at diagnosis (adjusted OR: 1.12, 95% CI 1.05-1.21; p value = 0.002). At 12 and 24 months, progression was noted in 27/105 (26%) and 48/113 (43%) patients, respectively. O exposure was associated with progression at 24 months (adjusted OR: 1.10, 95% CI 1.02-1.19; p value = 0.02). We found no association between exposure to other air pollutants and severity at diagnosis and progression. Our findings suggest that high levels of O exposure are associated with more severe SSc-associated ILD at diagnosis, and progression at 24 months.
doi_str_mv 10.1186/s12931-023-02463-w
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_46f9929ac5fb4a8293aeb88fce31d0ca</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A752370850</galeid><doaj_id>oai_doaj_org_article_46f9929ac5fb4a8293aeb88fce31d0ca</doaj_id><sourcerecordid>A752370850</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-607b4e4b2d70292cd9f07eb3625bcc4e04fdb289a9c45a0d9d2febaa4c7c5f2b3</originalsourceid><addsrcrecordid>eNptks1u1DAUhSMEoqXwAiyQJTbdpNjOj2M2qKr4qVQJJIrEznLs69RVxh5sZ0bzcjwbTqYtHYSiKNb1d86NfU9RvCb4jJCufRcJ5RUpMa3yW7dVuX1SHJO6bUrOq59PH62Pihcx3mJMWMea58VRxSgnTUuPi9_XN4BkjF5Zmax3qIe0BXBI2oDWfhynpSqdRimTETYQbNohmZC2cnA-2rjsroMfAsQ4096guIsJVlahqEYIM1XedwGNrEsQYrLJyhGNkxuyWQQZ4T3KHtOYIjLBr5aWAVLWr0EluwH0fbH75kcU06R3L4tnRo4RXt19T4ofnz5eX3wpr75-vrw4vypV09apbDHra6h7qhmmnCrNDWbQVy1teqVqwLXRPe245KpuJNZcUwO9lLViqjG0r06Ky72v9vJWrINdybATXlqxFHwYhAzJ5p8TdWs4p1xmYV_LLo9IQt91RkFFNFYye33Ye62nfgVagUtBjgemhzvO3ojBbwTJU-aE0exweucQ_K8JYhIrGxWMo3Tgpyhol-PQNZnO6Nt_0Fs_BZfvaqYYIQ0h7C81yHwC64zPjdVsKs5ZQyuGuwZn6uw_VH70PGnvwNhcPxDQvUDlCcYA5uGQBIs5wmIfYZEjLJYIi20WvXl8PQ-S-8xWfwChmPOi</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2827115117</pqid></control><display><type>article</type><title>The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Free E-Journal (出版社公開部分のみ)</source><creator>Roeser, Anaïs ; Sese, Lucile ; Chassagnon, Guillaume ; Chaigne, Benjamin ; Dunogue, Bertrand ; Tran Ba, Stéphane ; Jebri, Salma ; Brillet, Pierre-Yves ; Revel, Marie Pierre ; Aubourg, Frédérique ; Dhote, Robin ; Caux, Frédéric ; Annesi-Maesano, Isabella ; Mouthon, Luc ; Nunes, Hilario ; Uzunhan, Yurdagül</creator><creatorcontrib>Roeser, Anaïs ; Sese, Lucile ; Chassagnon, Guillaume ; Chaigne, Benjamin ; Dunogue, Bertrand ; Tran Ba, Stéphane ; Jebri, Salma ; Brillet, Pierre-Yves ; Revel, Marie Pierre ; Aubourg, Frédérique ; Dhote, Robin ; Caux, Frédéric ; Annesi-Maesano, Isabella ; Mouthon, Luc ; Nunes, Hilario ; Uzunhan, Yurdagül</creatorcontrib><description>To investigate the association of air pollution exposure with the severity of interstitial lung disease (ILD) at diagnosis and ILD progression among patients with systemic sclerosis (SSc)-associated ILD. We conducted a retrospective two-center study of patients with SSc-associated ILD diagnosed between 2006 and 2019. Exposure to the air pollutants particulate matter of up to 10 and 2.5 µm in diameter (PM , PM ), nitrogen dioxide (NO ), and ozone (O ) was assessed at the geolocalization coordinates of the patients' residential address. Logistic regression models were used to evaluate the association between air pollution and severity at diagnosis according to the Goh staging algorithm, and progression at 12 and 24 months. We included 181 patients, 80% of whom were women; 44% had diffuse cutaneous scleroderma, and 56% had anti-topoisomerase I antibodies. ILD was extensive, according to the Goh staging algorithm, in 29% of patients. O exposure was associated with the presence of extensive ILD at diagnosis (adjusted OR: 1.12, 95% CI 1.05-1.21; p value = 0.002). At 12 and 24 months, progression was noted in 27/105 (26%) and 48/113 (43%) patients, respectively. O exposure was associated with progression at 24 months (adjusted OR: 1.10, 95% CI 1.02-1.19; p value = 0.02). We found no association between exposure to other air pollutants and severity at diagnosis and progression. Our findings suggest that high levels of O exposure are associated with more severe SSc-associated ILD at diagnosis, and progression at 24 months.</description><identifier>ISSN: 1465-993X</identifier><identifier>ISSN: 1465-9921</identifier><identifier>EISSN: 1465-993X</identifier><identifier>EISSN: 1465-9921</identifier><identifier>DOI: 10.1186/s12931-023-02463-w</identifier><identifier>PMID: 37291562</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Air pollution ; Algorithms ; Antibodies ; Care and treatment ; Complications and side effects ; Composition ; Development and progression ; Diagnosis ; DNA topoisomerase ; Environmental aspects ; Exposure ; Health aspects ; Identification and classification ; Internal medicine ; Interstitial lung disease ; Lung diseases ; Lung diseases, Interstitial ; Lung transplants ; Mortality ; Nitrogen dioxide ; Outdoor air quality ; Ozone ; Particles ; Particulate emissions ; Particulate matter ; Pneumonia ; Pollutants ; Pulmonary fibrosis ; Regression analysis ; Regression models ; Rheumatology ; Scleroderma ; Scleroderma (Disease) ; Sensitivity analysis ; Systemic scleroderma ; Systemic sclerosis</subject><ispartof>Respiratory research, 2023-06, Vol.24 (1), p.151-151, Article 151</ispartof><rights>2023. The Author(s).</rights><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-607b4e4b2d70292cd9f07eb3625bcc4e04fdb289a9c45a0d9d2febaa4c7c5f2b3</citedby><cites>FETCH-LOGICAL-c564t-607b4e4b2d70292cd9f07eb3625bcc4e04fdb289a9c45a0d9d2febaa4c7c5f2b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249172/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2827115117?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37291562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roeser, Anaïs</creatorcontrib><creatorcontrib>Sese, Lucile</creatorcontrib><creatorcontrib>Chassagnon, Guillaume</creatorcontrib><creatorcontrib>Chaigne, Benjamin</creatorcontrib><creatorcontrib>Dunogue, Bertrand</creatorcontrib><creatorcontrib>Tran Ba, Stéphane</creatorcontrib><creatorcontrib>Jebri, Salma</creatorcontrib><creatorcontrib>Brillet, Pierre-Yves</creatorcontrib><creatorcontrib>Revel, Marie Pierre</creatorcontrib><creatorcontrib>Aubourg, Frédérique</creatorcontrib><creatorcontrib>Dhote, Robin</creatorcontrib><creatorcontrib>Caux, Frédéric</creatorcontrib><creatorcontrib>Annesi-Maesano, Isabella</creatorcontrib><creatorcontrib>Mouthon, Luc</creatorcontrib><creatorcontrib>Nunes, Hilario</creatorcontrib><creatorcontrib>Uzunhan, Yurdagül</creatorcontrib><title>The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study</title><title>Respiratory research</title><addtitle>Respir Res</addtitle><description>To investigate the association of air pollution exposure with the severity of interstitial lung disease (ILD) at diagnosis and ILD progression among patients with systemic sclerosis (SSc)-associated ILD. We conducted a retrospective two-center study of patients with SSc-associated ILD diagnosed between 2006 and 2019. Exposure to the air pollutants particulate matter of up to 10 and 2.5 µm in diameter (PM , PM ), nitrogen dioxide (NO ), and ozone (O ) was assessed at the geolocalization coordinates of the patients' residential address. Logistic regression models were used to evaluate the association between air pollution and severity at diagnosis according to the Goh staging algorithm, and progression at 12 and 24 months. We included 181 patients, 80% of whom were women; 44% had diffuse cutaneous scleroderma, and 56% had anti-topoisomerase I antibodies. ILD was extensive, according to the Goh staging algorithm, in 29% of patients. O exposure was associated with the presence of extensive ILD at diagnosis (adjusted OR: 1.12, 95% CI 1.05-1.21; p value = 0.002). At 12 and 24 months, progression was noted in 27/105 (26%) and 48/113 (43%) patients, respectively. O exposure was associated with progression at 24 months (adjusted OR: 1.10, 95% CI 1.02-1.19; p value = 0.02). We found no association between exposure to other air pollutants and severity at diagnosis and progression. Our findings suggest that high levels of O exposure are associated with more severe SSc-associated ILD at diagnosis, and progression at 24 months.</description><subject>Air pollution</subject><subject>Algorithms</subject><subject>Antibodies</subject><subject>Care and treatment</subject><subject>Complications and side effects</subject><subject>Composition</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>DNA topoisomerase</subject><subject>Environmental aspects</subject><subject>Exposure</subject><subject>Health aspects</subject><subject>Identification and classification</subject><subject>Internal medicine</subject><subject>Interstitial lung disease</subject><subject>Lung diseases</subject><subject>Lung diseases, Interstitial</subject><subject>Lung transplants</subject><subject>Mortality</subject><subject>Nitrogen dioxide</subject><subject>Outdoor air quality</subject><subject>Ozone</subject><subject>Particles</subject><subject>Particulate emissions</subject><subject>Particulate matter</subject><subject>Pneumonia</subject><subject>Pollutants</subject><subject>Pulmonary fibrosis</subject><subject>Regression analysis</subject><subject>Regression models</subject><subject>Rheumatology</subject><subject>Scleroderma</subject><subject>Scleroderma (Disease)</subject><subject>Sensitivity analysis</subject><subject>Systemic scleroderma</subject><subject>Systemic sclerosis</subject><issn>1465-993X</issn><issn>1465-9921</issn><issn>1465-993X</issn><issn>1465-9921</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptks1u1DAUhSMEoqXwAiyQJTbdpNjOj2M2qKr4qVQJJIrEznLs69RVxh5sZ0bzcjwbTqYtHYSiKNb1d86NfU9RvCb4jJCufRcJ5RUpMa3yW7dVuX1SHJO6bUrOq59PH62Pihcx3mJMWMea58VRxSgnTUuPi9_XN4BkjF5Zmax3qIe0BXBI2oDWfhynpSqdRimTETYQbNohmZC2cnA-2rjsroMfAsQ4096guIsJVlahqEYIM1XedwGNrEsQYrLJyhGNkxuyWQQZ4T3KHtOYIjLBr5aWAVLWr0EluwH0fbH75kcU06R3L4tnRo4RXt19T4ofnz5eX3wpr75-vrw4vypV09apbDHra6h7qhmmnCrNDWbQVy1teqVqwLXRPe245KpuJNZcUwO9lLViqjG0r06Ky72v9vJWrINdybATXlqxFHwYhAzJ5p8TdWs4p1xmYV_LLo9IQt91RkFFNFYye33Ye62nfgVagUtBjgemhzvO3ojBbwTJU-aE0exweucQ_K8JYhIrGxWMo3Tgpyhol-PQNZnO6Nt_0Fs_BZfvaqYYIQ0h7C81yHwC64zPjdVsKs5ZQyuGuwZn6uw_VH70PGnvwNhcPxDQvUDlCcYA5uGQBIs5wmIfYZEjLJYIi20WvXl8PQ-S-8xWfwChmPOi</recordid><startdate>20230608</startdate><enddate>20230608</enddate><creator>Roeser, Anaïs</creator><creator>Sese, Lucile</creator><creator>Chassagnon, Guillaume</creator><creator>Chaigne, Benjamin</creator><creator>Dunogue, Bertrand</creator><creator>Tran Ba, Stéphane</creator><creator>Jebri, Salma</creator><creator>Brillet, Pierre-Yves</creator><creator>Revel, Marie Pierre</creator><creator>Aubourg, Frédérique</creator><creator>Dhote, Robin</creator><creator>Caux, Frédéric</creator><creator>Annesi-Maesano, Isabella</creator><creator>Mouthon, Luc</creator><creator>Nunes, Hilario</creator><creator>Uzunhan, Yurdagül</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230608</creationdate><title>The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study</title><author>Roeser, Anaïs ; Sese, Lucile ; Chassagnon, Guillaume ; Chaigne, Benjamin ; Dunogue, Bertrand ; Tran Ba, Stéphane ; Jebri, Salma ; Brillet, Pierre-Yves ; Revel, Marie Pierre ; Aubourg, Frédérique ; Dhote, Robin ; Caux, Frédéric ; Annesi-Maesano, Isabella ; Mouthon, Luc ; Nunes, Hilario ; Uzunhan, Yurdagül</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-607b4e4b2d70292cd9f07eb3625bcc4e04fdb289a9c45a0d9d2febaa4c7c5f2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Air pollution</topic><topic>Algorithms</topic><topic>Antibodies</topic><topic>Care and treatment</topic><topic>Complications and side effects</topic><topic>Composition</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>DNA topoisomerase</topic><topic>Environmental aspects</topic><topic>Exposure</topic><topic>Health aspects</topic><topic>Identification and classification</topic><topic>Internal medicine</topic><topic>Interstitial lung disease</topic><topic>Lung diseases</topic><topic>Lung diseases, Interstitial</topic><topic>Lung transplants</topic><topic>Mortality</topic><topic>Nitrogen dioxide</topic><topic>Outdoor air quality</topic><topic>Ozone</topic><topic>Particles</topic><topic>Particulate emissions</topic><topic>Particulate matter</topic><topic>Pneumonia</topic><topic>Pollutants</topic><topic>Pulmonary fibrosis</topic><topic>Regression analysis</topic><topic>Regression models</topic><topic>Rheumatology</topic><topic>Scleroderma</topic><topic>Scleroderma (Disease)</topic><topic>Sensitivity analysis</topic><topic>Systemic scleroderma</topic><topic>Systemic sclerosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roeser, Anaïs</creatorcontrib><creatorcontrib>Sese, Lucile</creatorcontrib><creatorcontrib>Chassagnon, Guillaume</creatorcontrib><creatorcontrib>Chaigne, Benjamin</creatorcontrib><creatorcontrib>Dunogue, Bertrand</creatorcontrib><creatorcontrib>Tran Ba, Stéphane</creatorcontrib><creatorcontrib>Jebri, Salma</creatorcontrib><creatorcontrib>Brillet, Pierre-Yves</creatorcontrib><creatorcontrib>Revel, Marie Pierre</creatorcontrib><creatorcontrib>Aubourg, Frédérique</creatorcontrib><creatorcontrib>Dhote, Robin</creatorcontrib><creatorcontrib>Caux, Frédéric</creatorcontrib><creatorcontrib>Annesi-Maesano, Isabella</creatorcontrib><creatorcontrib>Mouthon, Luc</creatorcontrib><creatorcontrib>Nunes, Hilario</creatorcontrib><creatorcontrib>Uzunhan, Yurdagül</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Respiratory research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roeser, Anaïs</au><au>Sese, Lucile</au><au>Chassagnon, Guillaume</au><au>Chaigne, Benjamin</au><au>Dunogue, Bertrand</au><au>Tran Ba, Stéphane</au><au>Jebri, Salma</au><au>Brillet, Pierre-Yves</au><au>Revel, Marie Pierre</au><au>Aubourg, Frédérique</au><au>Dhote, Robin</au><au>Caux, Frédéric</au><au>Annesi-Maesano, Isabella</au><au>Mouthon, Luc</au><au>Nunes, Hilario</au><au>Uzunhan, Yurdagül</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study</atitle><jtitle>Respiratory research</jtitle><addtitle>Respir Res</addtitle><date>2023-06-08</date><risdate>2023</risdate><volume>24</volume><issue>1</issue><spage>151</spage><epage>151</epage><pages>151-151</pages><artnum>151</artnum><issn>1465-993X</issn><issn>1465-9921</issn><eissn>1465-993X</eissn><eissn>1465-9921</eissn><abstract>To investigate the association of air pollution exposure with the severity of interstitial lung disease (ILD) at diagnosis and ILD progression among patients with systemic sclerosis (SSc)-associated ILD. We conducted a retrospective two-center study of patients with SSc-associated ILD diagnosed between 2006 and 2019. Exposure to the air pollutants particulate matter of up to 10 and 2.5 µm in diameter (PM , PM ), nitrogen dioxide (NO ), and ozone (O ) was assessed at the geolocalization coordinates of the patients' residential address. Logistic regression models were used to evaluate the association between air pollution and severity at diagnosis according to the Goh staging algorithm, and progression at 12 and 24 months. We included 181 patients, 80% of whom were women; 44% had diffuse cutaneous scleroderma, and 56% had anti-topoisomerase I antibodies. ILD was extensive, according to the Goh staging algorithm, in 29% of patients. O exposure was associated with the presence of extensive ILD at diagnosis (adjusted OR: 1.12, 95% CI 1.05-1.21; p value = 0.002). At 12 and 24 months, progression was noted in 27/105 (26%) and 48/113 (43%) patients, respectively. O exposure was associated with progression at 24 months (adjusted OR: 1.10, 95% CI 1.02-1.19; p value = 0.02). We found no association between exposure to other air pollutants and severity at diagnosis and progression. Our findings suggest that high levels of O exposure are associated with more severe SSc-associated ILD at diagnosis, and progression at 24 months.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>37291562</pmid><doi>10.1186/s12931-023-02463-w</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1465-993X
ispartof Respiratory research, 2023-06, Vol.24 (1), p.151-151, Article 151
issn 1465-993X
1465-9921
1465-993X
1465-9921
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_46f9929ac5fb4a8293aeb88fce31d0ca
source Open Access: PubMed Central; Publicly Available Content Database (Proquest) (PQ_SDU_P3); Free E-Journal (出版社公開部分のみ)
subjects Air pollution
Algorithms
Antibodies
Care and treatment
Complications and side effects
Composition
Development and progression
Diagnosis
DNA topoisomerase
Environmental aspects
Exposure
Health aspects
Identification and classification
Internal medicine
Interstitial lung disease
Lung diseases
Lung diseases, Interstitial
Lung transplants
Mortality
Nitrogen dioxide
Outdoor air quality
Ozone
Particles
Particulate emissions
Particulate matter
Pneumonia
Pollutants
Pulmonary fibrosis
Regression analysis
Regression models
Rheumatology
Scleroderma
Scleroderma (Disease)
Sensitivity analysis
Systemic scleroderma
Systemic sclerosis
title The association between air pollution and the severity at diagnosis and progression of systemic sclerosis-associated interstitial lung disease: results from the retrospective ScleroPol study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A16%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20association%20between%20air%20pollution%20and%20the%20severity%20at%20diagnosis%20and%20progression%20of%20systemic%20sclerosis-associated%20interstitial%20lung%20disease:%20results%20from%20the%20retrospective%20ScleroPol%20study&rft.jtitle=Respiratory%20research&rft.au=Roeser,%20Ana%C3%AFs&rft.date=2023-06-08&rft.volume=24&rft.issue=1&rft.spage=151&rft.epage=151&rft.pages=151-151&rft.artnum=151&rft.issn=1465-993X&rft.eissn=1465-993X&rft_id=info:doi/10.1186/s12931-023-02463-w&rft_dat=%3Cgale_doaj_%3EA752370850%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-607b4e4b2d70292cd9f07eb3625bcc4e04fdb289a9c45a0d9d2febaa4c7c5f2b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2827115117&rft_id=info:pmid/37291562&rft_galeid=A752370850&rfr_iscdi=true